Merkel Cell Cancer
Diagnosis and management strategies for Merkel cell carcinoma of skin described
Published in Immunotherapy Weekly, June 15th, 2005
"MCC of the skin is a rare form of cutaneous malignancy of neuroendocrine origin with a propensity to affect predominately elderly patients in sun-exposed areas. The tumor has an extremely aggressive growth pattern with the potential to seed into the dermal lymphatics at an early stage as well as spread to nodes and distant sites," scientists in Australia reported.
"Successful outcomes can be achieved with early diagnosis and a multidisciplinary approach to management. Patients with MCC should be carefully staged to exclude distant metastatic disease. Treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2005-06-15)
More Articles from Immunotherapy Weekly
- Allergy Medicine
Peptide-based vaccines for allergic and autoimmune diseases reviewed - Arthritis
Loci on chromosomes 10 and 17 determine autoimmunity, arthritis susceptibility - Immunology
Autoreactive antibodies have role in overcoming acute rejection of grafts - Lymphopenia
Link between lymphopenia and autoimmunity may be reason for treatment failure - Vaccine Safety
Relation between vaccine refusal and atopic disease investigated - Acute Myeloid Leukemia
New findings in acute myeloid leukemia described - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
